Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

Plastomics, Inc. enhances its research and development capabilities with key new hire

June 28, 2021 at 09:03 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Industry veteran joins as Vice-President of Research and Development

SAINT LOUIS, MO, USA, June 28, 2021 /EINPresswire.com/ -- Plastomics, Inc., the biotechnology company developing a transformative platform for transgenic trait introduction via the chloroplast, announces the hire of distinguished industry veteran, Dr. Charles (Chuck) L. Armstrong, to the position of Vice President, Research and Development (R&D). Dr. Armstrong will join Dr. Jeffrey Staub, Chief Technology Officer (CTO) and Plastomics founder, in leading the overall R&D pipeline.

Dr. Armstrong joins Plastomics after an illustrious 33-year career at Monsanto Company and Bayer Crop Sciences. Among Chuck’s many career highlights are the publication of several early seminal works on corn transformation, the development of multiple transformation competent lines of maize still used routinely in both academia and industry, as well as being part of the team that generated the first fertile transgenic corn plants in 1990. Chuck has been honored as the recipient of numerous prestigious awards including the Queeny Award for his role in the development of RoundUp Ready^® 2 and Yieldgard^® Corn products, the Monsanto Science and Technology Career Award and the James B. Eads Award from the St. Louis Academy of Science. Chuck has been a Senior Science Fellow since 2002 and Associate Editor of In Vitro -Plant since 1992.

Dr. Staub commented, “I had the good fortune to work alongside Chuck for many years at Monsanto and more recently to benefit from his counsel as a member of the Plastomics Scientific Advisory Board. I’m thrilled to join forces with Chuck again to shepherd corn chloroplast transformation to a commercial reality.” Dr. Robert Fraley, Monsanto CTO over much of Chuck’s career noted, “Chuck brings a wealth of experience and expertise in the development of valuable new technologies to enhance corn productivity. He is a fantastic addition to the Plastomics team.”

“With the advancement of Plastomics’ soybean chloroplast pipeline to proof-of-concept for potential commercial product concepts, and the corn chloroplast transformation pipeline following closely behind, it has been important for us to add technical and strategic strength to augment the already strong core team”, stated Dr. Martha Schlicher, Plastomics CEO.

Plastomics continues to advance its transformative platforms for both soybeans and corn from laboratory to greenhouse testing. The chloroplast transformation trait introduction system has been demonstrated at greenhouse scale through two generations in soybean and the corn platform is advancing using multiple proprietary approaches. Chloroplast transformation provides many benefits not possible with traits introduced via the nucleus at a time when the industry is desperate for new solutions, including technology to overcome broad spread insect resistance to current commercial traits. These benefits include the introduction of traits with new modes of action and traits that have the potential to enhance yield – further reducing the environmental footprint of crop production.

About Plastomics, Inc.
Plastomics, Inc. is a novel early-stage biotechnology company developing a new and better way of introducing biotech traits into row crops like corn and soybeans. The St. Louis based company, resides in the 39 North innovation district with laboratories and corporate offices at Helix Incubator and greenhouse operations at the Donald Danforth Plant Science Center. Learn more at www.Plastomics.com

Martha Schlicher
Plastomics, Inc.
+1 314-703-7198
martha@plastomics.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article